Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Weight-loss drugs are not linked to suicidal thoughts.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Tofacitinib significantly improved skin and hair conditions without side effects.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.